Metris Therapeutics Ltd. is a University of Cambridge biotechnology spinoff that specializes in the research and development of medicines that treat gynecological or women's health disorders. The company is currently developing medicines to treat endometriosis, menstrual pain, and menopause symptoms. Johnson & Johnson is one of Metris' major backers. Company website does not exist.